Pick the relation: C = C₀·e−kt, LD = Vd·C/(S·F), maintenance rate = CL·Css/(S·F), τ = ln(Cpeak/Ctrough)/k.
For kidney function, estimate CrCl with Cockcroft–Gault first, then scale the dose or the interval.
Check the result: levels fall by half every half-life, and steady state takes about five half-lives.
2Practice problems
1.Pharmacy calculationsMedium
A solution has a ratio strength of 1:1000. You need 0.46 mg. Draw up the volume in the 1 mL syringe: what volume V is that?
1:10000.46 mg
V = mL
2.Pharmacy calculationsHard
A vial holds 250 mg of powder. You add 3.5 mL of diluent, and the powder adds 0.5 mL of volume. The prescription is 87.5 mg. Draw up the dose: what volume V do you give?
250 mg3.5 mL + 0.5 mL87.5 mg
V = mL
3.Dosage calculationsMedium
A child weighing 12 kg is prescribed 2 mg/kg of a drug. The stock solution contains 20 mg/mL. Draw up the dose: what volume V do you give?
12 kg2 mg/kg20 mg/mL
V = mL
4.Dosage calculationsHard
A patient is 157 cm tall and weighs 67 kg. The prescription is 75 mg/m². Using the Mosteller formula BSA = √(height (cm) × weight (kg)/3600), find the dose D in mg.
157 cm67 kg75 mg/m²
D = mg
5.Clinical pharmacokineticsMedium
Practice exercise (made-up values, not clinical guidance). After an IV dose of vancomycin, the level is 25 mg/L at 1 h and 12.5 mg/L at 13 h. Assume first-order elimination. Find the half-life t½.
C1 = 25 mg/L (1 h)C2 = 12.5 mg/L (13 h)
t½ = h
6.Clinical pharmacokineticsHard
Practice exercise (made-up values, not clinical guidance). A 45-year-old man weighs 52 kg and has a serum creatinine of 2 mg/dL (177 µmol/L). Estimate the creatinine clearance with Cockcroft–Gault: CrCl (mL/min) = (140 − age) × weight (kg)/(72 × SCr in mg/dL), × 0.85 for women. The usual levetiracetam dose is 1000 mg for a creatinine clearance of 120 mL/min, and a fraction fe = 0.66 of the drug is excreted unchanged by the kidneys. Using the Dettli dose fraction Q = 1 − fe·(1 − CrCl/normal CrCl), find the adjusted dose D. Round to the nearest whole number.
Strength to volume: turn the strength into mg per mL first. A w/v percentage is grams per 100 mL, so x% = 10x mg/mL. A ratio strength 1:n is 1 g in n mL. After reconstitution the concentration is the powder's dose over the final volume (diluent + powder volume). Then volume = dose/concentration.
Strength in mg/mL
1000 mg/1000 mL = 1 mg/mL
Volume
V = 0.46/1 = 0.46 mL
Answer
V = 0.46 mL
2.Pharmacy calculations
Answer: V = 1.4 mL
Strength to volume: turn the strength into mg per mL first. A w/v percentage is grams per 100 mL, so x% = 10x mg/mL. A ratio strength 1:n is 1 g in n mL. After reconstitution the concentration is the powder's dose over the final volume (diluent + powder volume). Then volume = dose/concentration.
Final volume and concentration
3.5 + 0.5 = 4 mL
C = 250/4 = 62.5 mg/mL
Volume
V = 87.5/62.5 = 1.4 mL
Answer
V = 1.4 mL
3.Dosage calculations
Answer: V = 1.2 mL
Drawing up a dose: volume = (prescribed dose/stock strength) × stock volume. Convert to the same units first, then check that the volume fits the syringe and lands on one of its graduations.
Dose from body weight
D = 2·12 = 24 mg
Volume
V = 24/20 = 1.2 mL
On the syringe
On this 10 mL syringe every small line is 0.2 mL.
Answer
V = 1.2 mL
4.Dosage calculations
Answer: D = 128.2 mg
Body-surface-area dosing: many cytotoxic and some paediatric doses are prescribed per square metre of body surface area: dose (mg) = dose per m² × BSA (m²). The Mosteller formula estimates BSA = √(height (cm) × weight (kg)/3600).
Body surface area
BSA = √(157·67/3600) = √2.922 = 1.709 m²
Dose
D = 75·1.709 = 128.2 mg
Answer
D = 128.2 mg
5.Clinical pharmacokinetics
Answer: t½ = 12 h
Clearance and volume: at steady state the dosing rate equals the elimination rate, so the maintenance rate = CL × Css. A loading dose is LD = Vd × C/(S × F), with S the salt factor (fraction of active drug in the salt) and F the bioavailability (1 for IV). From two levels, k = ln(C₁/C₂)/Δt; for an IV bolus Vd = dose/C₀ and CL = k × Vd. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Elimination rate constant
k = ln(25/12.5)/12 = 0.6931/12 = 0.05776 h⁻¹
Half-life
t½ = 0.693/0.05776 = 12 h
Answer
t½ = 12 h
6.Clinical pharmacokinetics
Answer: D = 529 mg
Designing a regimen: with rapid IV doses the level falls from peak to trough during the interval, so τ = ln(Cpeak/Ctrough)/k and the dose that restores the peak is Vd × (Cpeak − Ctrough). The average steady-state level is Css,avg = S·F·dose/(CL·τ). An infusion rises as C = (R/CL)(1 − e−kt). For a drug cleared by the kidneys, the dose is scaled with the creatinine clearance. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Creatinine clearance (Cockcroft–Gault)
CrCl = (140 − 45)·52/(72·2) = 34.31 mL/min
Dose fraction (Dettli)
Q = 1 − 0.66·(1 − 34.31/120) = 0.5287
Adjusted dose
D = 0.5287·1000 = 528.7 ≈ 529 mg
Answer
D = 529 mg
In practice the dose is rounded to a convenient amount and checked against the product information.